Overview

  • Product nameAnti-IGF2 antibody
    See all IGF2 primary antibodies
  • Description
    Rabbit polyclonal to IGF2
  • Tested applicationsSuitable for: Sandwich ELISA, Indirect ELISA, Neutralising, WB, ICC/IF, IHC-Pmore details
  • Species reactivity
    Reacts with: Recombinant Fragment
    Predicted to work with: Human
  • Immunogen

    Highly pure (>98%) recombinant Human IGF2.

Properties

Associated products

Applications

Our Abpromise guarantee covers the use of ab109789 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
Sandwich ELISA Use a concentration of 0.5 - 2 µg/ml. Can be paired for Sandwich ELISA with Rabbit polyclonal to IGF2 (Biotin) (ab83142). Using ab83142 as the detection antibody and ab109789 as the capture antibody, the detection limit for recombinant Human IGF2 is 0.2 - 0.4 ng/well, using 100 µl/well antibody solution.
Indirect ELISA Use a concentration of 0.5 - 2 µg/ml. (using 100 µl/well antibody solution) allows the detection of at least 0.2 - 0.4 ng/well of recombinant Human IGF2.
Neutralising Use a concentration of 3.1 - 4.6 µg/ml. to yield one-half maximal inhibition [ND50] of the biological activity of IGF2 (1.0 ng/ml)
WB Use a concentration of 0.1 - 0.2 µg/ml. Predicted molecular weight: 20 kDa. The detection limit for recombinant Human IGF2 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions
ICC/IF Use a concentration of 1 - 5 µg/ml.
IHC-P Use at an assay dependent concentration.

Target

  • FunctionThe insulin-like growth factors possess growth-promoting activity. In vitro, they are potent mitogens for cultured cells. IGF-II is influenced by placental lactogen and may play a role in fetal development.
    Preptin undergoes glucose-mediated co-secretion with insulin, and acts as physiological amplifier of glucose-mediated insulin secretion. Exhibits osteogenic properties by increasing osteoblast mitogenic activity through phosphoactivation of MAPK1 and MAPK3.
  • Involvement in diseaseEpigenetic changes of DNA hypomethylation in IGF2 are a cause of Silver-Russell syndrome (SIRS) [MIM:180860]. SIRS is a clinically heterogeneous condition characterized by severe intrauterine growth retardation, poor postnatal growth, craniofacial features such as a triangular shaped face and a broad forehead, body asymmetry, and a variety of minor malformations.
  • Sequence similaritiesBelongs to the insulin family.
  • Post-translational
    modifications
    O-glycosylated with a core 1 or possibly core 8 glycan.
  • Cellular localizationSecreted.
  • Information by UniProt
  • Database links
  • Alternative names
    • C11orf43 antibody
    • IGF 2 antibody
    • IGF II antibody
    • IGF-II antibody
    • IGF2 antibody
    • IGF2_HUMAN antibody
    • IGFII antibody
    • INSIGF antibody
    • insulin like growth factor 2 (somatomedin A) antibody
    • Insulin like Growth Factor 2 antibody
    • Insulin like growth factor II antibody
    • Insulin like growth factor II precursor antibody
    • Insulin like growth factor type 2 antibody
    • pp9974 antibody
    • Preptin antibody
    • putative insulin like growth factor II associated protein antibody
    • Somatomedin A antibody
    • Somatomedin-A antibody
    see all

References for Anti-IGF2 antibody (ab109789)

This product has been referenced in:
  • Hartnell A  et al. Identification of selective basophil chemoattractants in human nasal polyps as insulin-like growth factor-1 and insulin-like growth factor-2. J Immunol 173:6448-57 (2004). Read more (PubMed: 15528386) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab109789.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"